Showing results (1-10 of 290) with videos related to
Sort By:
Pageof 29
Best Practice & Research. Clinical Obstetrics & Gynaecology|March 6, 2012
Overview of microbicides for the prevention of human immunodeficiency virusSalim S Abdool Karim, Cheryl BaxterCurrent Topics in Microbiology and Immunology|May 23, 2013
Microbicides for prevention of HIV infection: clinical efficacy trialsSalim S Abdool Karim, Cheryl BaxterCurrent Opinion in Infectious Diseases|November 29, 2012
When to start antiretroviral therapy during tuberculosis treatment?Kogieleum Naidoo, Cheryl Baxter, Salim S Abdool KarimPlos Medicine|November 29, 2021
COVID-19 in Africa: Catalyzing change for sustainable developmentSalim S Abdool Karim, Segenet Kelemu, Cheryl BaxterCurrent Opinion in HIV and AIDS|February 21, 2015
Antibodies for HIV prevention in young womenSalim S Abdool Karim, Quarraisha Abdool Karim, Cheryl BaxterAntiviral Therapy|May 2, 2022
Advancing HIV prevention using tenofovir-based pre-exposure prophylaxisSalim S Abdool Karim, Cheryl Baxter, Quarraisha Abdool KarimCurrent Opinion in HIV and AIDS|October 24, 2017
The microbiome and HIV prevention strategies in womenSalim S Abdool Karim, Jo-Ann S Passmore, Cheryl BaxterInfectious Disease Clinics of North America|May 16, 2007
Global epidemiology of HIV-AIDSSalim S Abdool Karim, Quarraisha Abdool Karim, Eleanor Gouws, et al.Obstetrics and Gynecology|September 22, 2011
Contraceptive choices, pregnancy rates, and outcomes in a microbicide trialSengeziwe Sibeko, Cheryl Baxter, Nonhlanhla Yende, et al.The Journal of Infectious Diseases|July 1, 2020
Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A ReviewSharana Mahomed, Nigel Garrett, Cheryl Baxter, et al.Pageof 29